tradingkey.logo
Search
Markets
News
Analysis
Tools
Learn
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search
NewsOther

Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate

ReutersApr 9, 2026 11:15 AM
facebooktwitterlinkedin

April 9 (Reuters) - Kymera Therapeutics Inc KYMR.O:

  • KYMERA THERAPEUTICS ANNOUNCES GILEAD SCIENCES’ OPTION EXERCISE TO LICENSE KT-200, ORAL CDK2 MOLECULAR GLUE DEGRADER DEVELOPMENT CANDIDATE

  • KYMERA THERAPEUTICS INC - TO RECEIVE $45 MILLION MILESTONE PAYMENT FROM GILEAD FOR KT-200 OPTION

  • KYMERA THERAPEUTICS INC - ELIGIBLE FOR UP TO $750 MILLION IN TOTAL PAYMENTS UNDER AGREEMENT

  • KYMERA THERAPEUTICS INC - HAS REALIZED $85 MILLION IN UPFRONT AND OPTION PAYMENTS TO DATE

  • KYMERA THERAPEUTICS INC - MAY RECEIVE TIERED ROYALTIES FROM HIGH SINGLE-DIGIT TO MID-TEENS ON SALES

  • KYMERA THERAPEUTICS INC - GILEAD TO ADVANCE KT-200 INTO IND-ENABLING STUDIES FOR 2027 IND FILING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Strait of Hormuz Stalls Again, Safe-Haven Trade May Restart. Where Will Global Assets Go?

TradingKey - On April 17, Eastern Time, Iranian Foreign Minister Araghchi announced that the Strait of Hormuz would be "open to all commercial vessels during the Lebanon-Israel ceasefire." International oil prices plunged more than 10% in a single day, with WTI crude oil futures dropping to $84/barrel and Brent crude falling to $90/barrel.
TradingKey4 hours ago

Can Apple Stock Thrive in the AI Revolution Despite Market Challenges?

TradingKey - The increasing adoption of artificial intelligence, a shift in China's economy, and tighter valuation metrics are part of the ongoing discussion around Apple stock, which remains at the heart of this discussion. 
TradingKey15 hours ago

Intel Q1 Earnings Preview: Triple Test of CPU, 18A Yields and Foundry Orders

TradingKey - Intel (INTC) will report its Q1 results after the market close on April 23 (ET). As of mid-April, the consensus analyst estimate for Q1 revenue is approximately $12.32 billion, a year-over-year decline of about 2.75%, with earnings per share (EPS) projected at roughly $0.01.
TradingKey18 hours ago

Gold Outlook: Amid U.S.-Iran Tensions, Will Gold Prices Rise or Fall?

TradingKey - Gold prices have recently maintained high-level volatility amid fluctuating US-Iran tensions. While sustained high oil prices have significantly raised US inflation expectations, thereby lowering the probability of Federal Reserve interest rate cuts, the continuous accumulation of gold by global central banks still supports the long-term bullish thesis for the metal.
TradingKey21 hours ago

TSLA Q1 Earnings Preview: Tesla Snaps 8-Week Slump—Now Buy the Dip or Wait?

TradingKey - The report for Q1 2026 results from Tesla (TSLA) is due on Wednesday, April 22, at the end of the market. After two months of pretty continuous drops, investors are now asking if the TSLA earnings report will provide any insight into the company's margin, growth rate, and overall AI roa
TradingKey23 hours ago
Featured Tools
marketing_marketsTitleMarketscalendar_economicCalendarEconomic Calendarsearch.intelligent.strategySmartPicksarticle_asider_weekly_reportWeekly Report
Top News
link
Netflix Q1 2026 Earnings Preview: After Acquisition Turmoil, Where Is This Streaming Giant’s Growth Confidence?
Allbirds Abandons Shoes for AI, Shares Surge 600%, Can the Transformation Succeed?
Why AMD Stock Popped: 12-Day Winning Rally Signals CPU Renaissance in Agentic AI Push
Why Is Ethereum Stalling While Bitcoin Surges? Will It Ever Reach $10,000?
APLD Stock Surge: How CoreWeave Lease Amendments and Delta Forge 1 Milestones De-risk the Bull Case
Tradingkey
Tradingkey
KeyAI